Suppr超能文献

抗高血压药物对肾素-血管紧张素系统的作用。

Effect of antihypertensive drugs on the renin-angiotensin system.

作者信息

Johnston C I

出版信息

Drugs. 1976;12(4):274-91. doi: 10.2165/00003495-197612040-00003.

Abstract

Renin release from the kidneys is controlled by four major mechanisms - renal baroreceptors, the macula densa, the sympathetic nervous system and other humoral and ionic influences. Recently, the importance of the sympathetic nervous system in modulating renin release for a variety of stimuli has become apparent. The sympathetic adrenergic nerves act on a specific beta-receptor to stimulate renin release from the kidney. Those antihypertensive drugs that inhibit adrenergic nerve transmission tend therefore to lower plasma renin. beta-Adrenoreceptor blocking drugs also generally lower plasma renin by specific inhibition of renal renin release both in animals and humans. Diuretics and vasodilators in contrast elevate plasma renin levels. Plasma renin levels in hypertensive patients are the net result of many diverse influences, and similarly in patients treated with antihypertensive drugs the plasma renin level often is the result of opposing influences. Plasma renin levels tend to return towards normal levels after treatment in hypertensive patients. Plasma renin levels may offer a guide to a more rational basis for antihypertensive therapy in the future. However, the primary aim in treatment of the hypertensive patient should be to lower his blood pressure, independent of the effect of plasma renin levels.

摘要

肾脏释放肾素受四种主要机制控制——肾压力感受器、致密斑、交感神经系统以及其他体液和离子影响。最近,交感神经系统在调节多种刺激下肾素释放方面的重要性已变得明显。交感肾上腺素能神经作用于特定的β受体,以刺激肾脏释放肾素。因此,那些抑制肾上腺素能神经传递的抗高血压药物往往会降低血浆肾素水平。β肾上腺素受体阻断药物通常也通过特异性抑制动物和人类肾脏肾素释放来降低血浆肾素水平。相比之下,利尿剂和血管扩张剂会提高血浆肾素水平。高血压患者的血浆肾素水平是多种不同影响的综合结果,同样,在接受抗高血压药物治疗的患者中,血浆肾素水平往往也是相反影响的结果。高血压患者治疗后血浆肾素水平往往会趋于恢复正常水平。血浆肾素水平可能为未来更合理的抗高血压治疗提供指导。然而,治疗高血压患者的首要目标应该是降低其血压,而不考虑血浆肾素水平的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验